Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure

The purpose of this study is the observation of the course of

* the mechanics of the respiratory system * the endexpiratory lung volume * and the inflammatory response in patients undergoing treatment with extracorporeal life support (ECLS) due to severe refractory respiratory failure at our department.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Distress Syndrome, Adult Lung Diseases Respiration Disorders Respiratory Distress Syndrome Respiratory Distress Syndrome, Child Respiratory Tract Diseases

Age range

3 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ECMO Centre Karolinska

Solna, Stockholm County, 17176, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients accepted for extracorporeal life support at our department due to the most severe forms of ARDS/respiratory failure not responding to conventional therapy.

Exclusion criteria

malignant disease with a poor prognosis
massive intracranial bleeding

Treatment and study plan

Primary outcomes

Course of inflammatory parameters and lung function

Time frame: end of treatment

Sponsors and collaborators

Lead sponsor

Karolinska University Hospital

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Nov 9, 2011
Registry last updated: Dec 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed